the Role of Probiotic in Protein Metabolism

Inclusion criteria

• Voluntarily, in writing, and signing the informed consent form, agreeing to participate in this study;
• Agree to abide by the protocol and study restrictions;
• The subject is not allergic to protein products;
• Male or female subjects aged 18 to 35 years old (including 18 and 35 years old);
• Male subjects should weigh no less than 50 kilograms. Female subjects must weigh no less than 45 kg. Body mass index (BMI) = weight (kg)/height (m)2, body mass index is in the range of 19.0 to 24.0 kg/m2;
• No history of hidden risks of cardiovascular and cerebrovascular diseases, hypertension, diabetes, liver/kidney function, etc. and metabolic abnormalities.

Exclusion criteria

• Patients with allergies and immune deficiency;
• Donated blood or lost a large amount of blood (≥200 mL) within 3 months before taking the trial drug;
• Other systemic diseases, including cardiovascular disease, lung disease, liver disease, kidney disease and other serious lesions of important organs, severe metabolic diseases (diabetes, thyroid disease), severe immune system diseases; no cardiovascular and cerebrovascular diseases, hypertension , diabetes, liver/kidney function and other hidden dangers and metabolic abnormalities.
• Drugs that affect intestinal flora (including antibacterial drugs, microecological preparations, intestinal mucosal protective agents, Chinese patent medicines, etc.) have been used continuously for more than 1 week within 1 month before screening;
• Subjects judged by other researchers to be unfit to participate.